[1]CurrentPatentAssignee:APOGEEBIOTECHNOLOGYCORPORATION;EHPOUDZHIBIOTEKNOLODZHI-US2006/287317,2006,A1Locationinpatent:Page/Pagecolumn34-35
[1]CurrentPatentAssignee:APOGEEBIOTECHNOLOGYCORPORATION;EHPOUDZHIBIOTEKNOLODZHI-US2006/287317,2006,A1Locationinpatent:Page/Pagecolumn34-35
[1]CurrentPatentAssignee:TIANJINMINXIANGPHARMACEUTICALCOLTD-CN116217468,2023,ALocationinpatent:Paragraph0054-0062
Title: Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20160301
Title: Effect of alkyl chain length on sphingosine kinase 2 selectivity.
Journal: Bioorganic & medicinal chemistry letters 20121115
Title: Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.
Journal: Experimental biology and medicine (Maywood, N.J.) 20120701
Title: Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
Journal: Thrombosis and haemostasis 20120301
Title: Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.
Journal: Journal of hepatology 20120101
Title: Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.
Journal: PloS one 20120101
Title: Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
Journal: Investigational new drugs 20111201
Title: Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase.
Journal: Inflammopharmacology 20110401
Title: Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
Journal: Cancer biology & therapy 20110401
Title: Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Journal: Cancer biology & therapy 20110301
Title: Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2.
Journal: Pharmacology 20110101
Title: Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.
Journal: Endocrinology 20101101
Title: Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
Journal: Carcinogenesis 20101001
Title: A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
Journal: The Journal of pharmacology and experimental therapeutics 20100501
Title: Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Journal: Inflammopharmacology 20100401
Title: Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases.
Journal: Investigative ophthalmology & visual science 20061101
Title: French KJ, et al. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther. 2010 Apr;333(1):129-39.
Title: Beljanski V, et al. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs. 2011 Dec;29(6):1132-42.
Title: Shi Y, et al. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. J Hepatol. 2012 Jan;56(1):137-45.
Title: Liu Q, et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. PLoS One. 2012;7(7):e41834.
